A Network Pharmacology Analysis of Cang Fu Dao Tan Formula for the Treatment of Obese Polycystic Ovary Syndrome

A Network Pharmacology Analysis of Cang Fu Dao Tan Formula for the Treatment of Obese Polycystic Ovary Syndrome

Objective: To explore the potential molecular targets of Cang Fu Dao Tan Formula (CFDTF) in the treatment of obese polycystic ovary syndrome (PCOS) using network pharmacology and bioinformatic approaches. Methods: The potential blood-entry active compounds and targets of CFDTF were retrieved from th...

Full description

Bibliographic Details
Main Authors:	C.A.I. Meng-Cheng, J.I.N. Yong-Sheng, Y.U. Chao-Qin, Cheng Wen
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2020-09-01
Series:	Digital Chinese Medicine
Subjects:	Cang Fu Dao Tan Formula (CFDTF) Polycystic ovary syndrome (PCOS) Network pharmacology Quercetin AGE-RAGE signaling pathway
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589377720300513

Similar Items

ẢNH HƯỞNG CỦA OXY HÒA TAN LÊN SỬ DỤNG THỨC ĂN VÀ TĂNG TRƯỞNG CỦA TÔM CÀNG XANH (MACROBRACHIUM ROSENBERGII)
by: Triệu Thanh Tuấn, et al.
Published: (2011-05-01)

Inter-observer variability in the assessment of ultrasound features of polycystic ovaries
by: Rami Kilani, et al.
Published: (2017-09-01)

The relationship between intestinal microbiota and polycystic ovary syndrome
by: Katarzyna Korabiusz, et al.
Published: (2019-05-01)

Polycystic ovary syndrome (PCOS) - risk factor, diagnostic and current treatment
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Kymographic characteristics of voice in women with Polycystic ovary syndrome
by: Saranya Blahayil, et al.
Published: (2021-06-01)

Value of ultrasonography in the diagnosis of polycystic ovary syndrome – literature review
by: Michał Bachanek, et al.
Published: (2015-12-01)

Psychiatric Disorders in Infertile Women with Polycystic Ovary: Prevalence and Associated Factors
by: Mohammed Abo-Elabbas, et al.
Published: (2022-09-01)

Increased masked hypertension prevalence in patients with polycystic ovary syndrome (PCOS)
by: Selçuk Özkan, et al.
Published: (2020-11-01)

Comparison of maternal and fetal complications in women with various phenotypes of polycystic ovary syndrome
by: Marzieh Rostami Dovom, et al.
Published: (2020-05-01)

Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome
by: Mohd Zahoor ul haq Shah, et al.
Published: (2023-04-01)

Potential Role of Quercetin in Polycystic Ovary Syndrome and Its Complications: A Review
by: Tong Chen, et al.
Published: (2022-07-01)

Self-Confidence in Women with and without Polycystic Ovary Syndrome.
by: Leila Amini, et al.
Published: (2014-09-01)

The effect of metformin on uteroplacental circulation and pregnancy outcomes in pregnant women with Polycystic Ovary Syndrome
by: Jamal A, et al.
Published: (2010-07-01)

Evaluation of serum Podocalyxin in Iraqi women with Polycystic Ovary Syndrome
by: Noor Mohammed Fadhil, et al.
Published: (2023-01-01)

Editorial: Polycystic ovary syndrome: mechanism and management—volume II
by: Yishu Wang, et al.
Published: (2023-07-01)

Ovulation induction techniques in women with polycystic ovary syndrome
by: Andreas A. Vyrides, et al.
Published: (2022-08-01)

Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
by: Farnaz Shishehgar, et al.
Published: (2019-09-01)

Metabolomic Insight into Polycystic Ovary Syndrome—An Overview
by: Anna Rajska, et al.
Published: (2020-07-01)

Type and Frequency in Use of Nutraceutical and Micronutrient Supplementation for the Management of Polycystic Ovary Syndrome: A Systematic Scoping Review
by: Nicole Scannell, et al.
Published: (2023-12-01)

INNOVATIVE TREATMENT TECHNIQUES IN POLYCYSTIC OVARY SYNDROME (PCOS)
by: Cristina Raluca Iorga, et al.
Published: (2023-12-01)

The Role of the Gut Microbiome in Youth with Polycystic Ovary Syndrome: A Systematic Review
by: Vasiliki-Rengina Tsinopoulou, et al.
Published: (2023-11-01)

Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
by: Afrin Yasmin, et al.
Published: (2022-11-01)

Comparing Sexual Function and Quality of Life in Polycystic Ovary Syndrome and Healthy Women
by: Vida Shafti, et al.
Published: (2016-08-01)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
by: Wang Fang, et al.
Published: (2012-05-01)

The prevalence and phenotypic manifestations of polycystic ovary syndrome (PCOS) among infertile Sudanese women: a cross-sectional study
by: Alawia N. Elasam, et al.
Published: (2022-05-01)

Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis
by: Yiming Gao, et al.
Published: (2023-01-01)

Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes?
by: Maryam Eftekhar, et al.

Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update
by: Nicia I. Profili, et al.
Published: (2024-01-01)

Quercetin and polycystic ovary syndrome
by: Congshun Ma, et al.
Published: (2022-12-01)

Serum leptin level in obese women with polycystic ovary syndrome, and its relation to insulin resistance
by: Azhar Mohammad Nomair, et al.
Published: (2014-12-01)

The impact of using probiotics on metabolic disorders of women with polycystic ovary syndrome
by: Zuzanna Wesołowska, et al.
Published: (2023-02-01)

Effect of Ramadan Fasting on Stress Neurohormones in Women with Polycystic Ovary Syndrome.
by: Farideh Zangeneh, et al.
Published: (2015-06-01)

Effects of Etisterone and Contrasmine pills on clinical and biochemical findings of hyperandrogenism and metabolic parameters of patients with polycystic ovary syndrome: A randomized clinical trial
by: Mina Amiri, et al.
Published: (2020-08-01)

The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial
by: Mostafa Qorbani, et al.
Published: (2020-12-01)

Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics
by: Minhthao Thi Nguyen, et al.
Published: (2023-01-01)

Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
by: Ana Teresa Brinca, et al.
Published: (2022-05-01)

Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature
by: Stefano Palomba, et al.
Published: (2023-08-01)

Different sleep pattern in over-weight/obese women with polycystic ovary syndrome
by: Emma Oberg, et al.
Published: (2023-02-01)

Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial
by: Neda Rezvan, et al.
Published: (2017-11-01)

Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England
by: Anuradhaa Subramanian, et al.
Published: (2022-08-01)